{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Mazzoni E, Frontini F, Rotondo JCharles, Zanotta N, Fioravanti A, Minelli F, Torreggiani E, Campisciano G, Marcuzzi A, Guerra G, Tommasini A, Touz\'e9 A, Martini F, Tognon M, Comar M. Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. J Cell Physiol 2019;234(4):3170-3179.\par \par Bernardi S, Marcuzzi A, Piscianz E, Tommasini A, Fabris B. The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases. Int J Mol Sci 2018;19(12)\par \par Ferrara G, Pastore S, Sancin L, Torelli L, Radillo O, Bramuzzo M, Bibalo C, Tommasini A, Ventura A, Taddio A. Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis. J Rheumatol 2018;45(10):1418-1421.\par \par Girardelli M, Basaldella F, Paolera SDella, Vuch J, Tommasini A, Martelossi S, Crovella S, Bianco AMonica. Genetic profile of patients with early onset inflammatory bowel disease. Gene 2018;645:18-29.\par \par De Rose DUmberto, Giliani S, Notarangelo LDora, Lougaris V, Lanfranchi A, Moratto D, Martire B, Specchia F, Tommasini A, Plebani A, Badolato R. Long term outcome of eight patients with type 1 Leukocyte Adhesion Deficiency (LAD-1): Not only infections, but high risk of autoimmune complications. Clin Immunol 2018;191:75-80.\par \par Nocerino A, Valencic E, Loganes C, Pelos G, Tommasini A. Low-dose sirolimus in two cousins with autoimmune lymphoproliferative syndrome-associated infection. Pediatr Int 2018;60(3):315-317.\par \par Marcuzzi A, Loganes C, Valencic E, Piscianz E, Monasta L, Bilel S, Bortul R, Celeghini C, Zweyer M, Tommasini A. Neuronal Dysfunction Associated with Cholesterol Deregulation. Int J Mol Sci 2018;19(5)\par \par Lucaf\'f2 M, Di Silvestre A, Romano M, Avian A, Antonelli R, Martelossi S, Naviglio S, Tommasini A, Stocco G, Ventura A, Decorti G, De Iudicibus S. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease. Basic Clin Pharmacol Toxicol 2018;122(1):87-93.\par \par Valencic E, Grasso AGiacomo, Conversano E, Lucaf\'f2 M, Piscianz E, Gregori M, Conti F, Cancrini C, Tommasini A. Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency. J Allergy Clin Immunol Pract 2018;6(6):2165-2167.\par \par Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, Conti G, Marchetti F, Picco P, Tommasini A, Martino S, Malattia C, Gallizi R, Podda RAnna, Salis A, Falcini F, Schena F, Garbarino F, Morreale A, Pardeo M, Ventrici C, Passarelli C, Zhou Q, Severino M, Gandolfo C, Damonte G, Martini A, Ravelli A, Aksentijevich I, Ceccherini I, Gattorno M. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis 2017;76(10):1648-1656.\par \par Loganes C, Lega S, Bramuzzo M, Brumatti LVecchi, Piscianz E, Valencic E, Tommasini A, Marcuzzi A. Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage. Nutrients 2017;9(6)\par \par Taddio A, Rossi EDei, Monasta L, Pastore S, Tommasini A, Lepore L, Bronzetti G, Marrani E, Mottolese BD'Agata, Simonini G, Cimaz R, Ventura A. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Clin Rheumatol 2017;36(1):223-228.\par \par Piscianz E, Candilera V, Valencic E, Loganes C, Paron G, De Iudicibus S, Decorti G, Tommasini A. Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes. Mol Med Rep 2016;14(1):574-82.\par \par Abate MValentina, Stocco G, Devescovi R, Carrozzi M, Pierobon C, Valencic E, Lucaf\'f2 M, Di Silvestre A, d'Adamo P, Tommasini A, Decorti G, Ventura A. Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis. Blood Cells Mol Dis 2016;59:97-9.\par \par Naselli A, Penco F, Cantarini L, Insalaco A, Alessio M, Tommasini A, Maggio C, Obici L, Gallizi R, Cimmino M, Signa S, Lucherini OMaria, Carta S, Caroli F, Martini A, Rubartelli A, Ceccherini I, Gattorno M. Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study. J Rheumatol 2016;43(6):1093-100.\par \par Lucaf\'f2 M, Bravin V, Tommasini A, Martelossi S, Rabach I, Ventura A, Decorti G, De Iudicibus S. Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance. Clin Exp Pharmacol Physiol 2016;43(6):602-5.\par \par Marcuzzi A, Vozzi D, Girardelli M, Tricarico PMaura, Knowles A, Crovella S, Vuch J, Tommasini A, Piscianz E, Bianco AMonica. Putative modifier genes in mevalonate kinase deficiency. Mol Med Rep 2016;13(4):3181-9.\par \par Lougaris V, Faletra F, Lanzi G, Vozzi D, Marcuzzi A, Valencic E, Piscianz E, Bianco AM, Girardelli M, Baronio M, Loganes C, Fasth A, Salvini F, Trizzino A, Moratto D, Facchetti F, Giliani S, Plebani A, Tommasini A. Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. Clin Immunol 2015;159(1):33-6.\par \par Paloni G, Pastore S, Tommasini A, Lepore L, Taddio A. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy. Clin Exp Rheumatol 2015;33(5):766.\par \par Girardelli M, Arrigo S, Barabino A, Loganes C, Morreale G, Crovella S, Tommasini A, Bianco AMonica. The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency. BMC Pediatr 2015;15(1):208.\par \par De Pieri C, Taddio A, Insalaco A, Barbi E, Lepore L, Ventura A, Tommasini A. Different presentations of mevalonate kinase deficiency: a case series. Clin Exp Rheumatol 2015;33(3):437-42.\par \par Taddio A, Tommasini A, Valencic E, Biagi E, Decorti G, De Iudicibus S, Cuzzoni E, Gaipa G, Badolato R, Prandini A, Biondi A, Ventura A. Failure of interferon-? pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease. World J Gastroenterol 2015;21(14):4379-84.\par \par Pastore S, Vuch J, Bianco AMonica, Taddio A, Tommasini A. Fever tree revisited: From malaria to autoinflammatory diseases. World J Clin Pediatr 2015;4(4):106-12.\par \par De Pieri C, Vuch J, De Martino E, Bianco AM, Ronfani L, Athanasakis E, Bortot B, Crovella S, Taddio A, Severini GM, Tommasini A. Genetic profiling of autoinflammatory disorders in patients with periodic fever: a prospective study. Pediatr Rheumatol Online J 2015;13:11.\par \par Bianco AMonica, Girardelli M, Tommasini A. Genetics of inflammatory bowel disease from multifactorial to monogenic forms. World J Gastroenterol 2015;21(43):12296-310.\par \par Rusmini M, Federici S, Caroli F, Grossi A, Baldi M, Obici L, Insalaco A, Tommasini A, Caorsi R, Gallo E, Olivieri ANunzia, Marzano AV, Coviello D, Ravazzolo R, Martini A, Gattorno M, Ceccherini I. Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. Ann Rheum Dis 2015;\par \par Stocco G, Lanzi G, Yue F, Giliani S, Sasaki K, Tommasini A, Pelin M, Martelossi S, Ventura A, Decorti G. Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?. Curr Drug Metab 2015;17(1):91-8.\par \par Marcuzzi A, Piscianz E, Valencic E, Monasta L, Brumatti LVecchi, Tommasini A. To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies. Int J Mol Sci 2015;16(9):21277-93.\par \par Bianco AMonica, Faletra F, Vozzi D, Girardelli M, Knowles A, Tommasini A, Zauli G, Marcuzzi A. Two?gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results. Mol Med Rep 2015;12(4):6128-32.\par \par Frausin S, Viventi S, Falzacappa LVerga, Quattromani MJlenia, Leanza G, Tommasini A, Valencic E. Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem 2015;117(4-5):329-38.\par \par Copetti V, Pastore S, De Pieri C, Radillo O, Taddio A, Ventura A, Tommasini A. Clinical significance of hyper-IgA in a paediatric laboratory series. Arch Dis Child 2014;99(12):1114-6.\par \par De Pieri C, Vuch J, Athanasakis E, Severini GMaria, Crovella S, Bianco AMonica, Tommasini A. F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls. Clin Exp Rheumatol 2014;32(6):993-4.\par \par Piscianz E, Valencic E, Cuzzoni E, De Iudicibus S, De Lorenzo E, Decorti G, Tommasini A. Fate of lymphocytes after withdrawal of tofacitinib treatment. PLoS One 2014;9(1):e85463.\par \par Pastore S, Barbieri F, Di Leo G, Valencic E, Tommasini A, Ventura A. Hemophagocytic lymphohistiocytosis in total parenteral nutrition dependent children: description of 5 cases and practical tips for management. J Pediatr Hematol Oncol 2014;36(7):e440-2.\par \par Comar M, Delbue S, Zanotta N, Valencic E, Piscianz E, Del Savio R, Tesser A, Tommasini A, Ferrante P. In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords. Pediatr Blood Cancer 2014;61(8):1347-9.\par \par Valencic E, Loganes C, Cesana S, Piscianz E, Gaipa G, Biagi E, Tommasini A. Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. Stem Cell Res Ther 2014;5(1):3.\par \par Girardelli M, Vuch J, Tommasini A, Crovella S, Bianco AMonica. Novel missense mutation in the NOD2 gene in a patient with early onset ulcerative colitis: causal or chance association?. Int J Mol Sci 2014;15(3):3834-41.\par \par Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, Fabretto A, Vignola S, Lonardi S, Ventura A. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis 2014;8(8):770-4.\par \par Franca R, Rebora P, Athanasakis E, Favretto D, Verzegnassi F, Basso G, Tommasini A, Valsecchi MGrazia, Decorti G, Rabusin M. TNF-? SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype. Pharmacogenomics 2014;15(5):619-27.\par \par Bianco AMonica, Zanin V, Girardelli M, Magnolato A, Martelossi S, Martellossi S, Tommasini A, Marcuzzi A, Crovella S. A common genetic background could explain early-onset Crohn's disease. Med Hypotheses 2012;78(4):520-2.\par \par Notarangelo LDaniele, Tommasini A. Defective and excessive immunities in pediatric diseases. Curr Pharm Des 2012;18(35):5729-34.\par \par Tommasini A, Valencic E, Piscianz E, Rabusin M. Immunomodulatory drugs in autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer 2012;58(2):310; author reply 311.\par \par Marcuzzi A, Girardelli M, Bianco AMonica, Martelossi S, Magnolato A, Tommasini A, Crovella S. Inflammation profile of four early onset Crohn patients. Gene 2012;493(2):282-5.\par \par Comar M, Secchiero P, De Lorenzo E, Martelossi S, Tommasini A, Zauli G. JCV+ Patients with Inflammatory bowel disease show elevated plasma levels of MIG and SCF. Inflamm Bowel Dis 2012;18(6):1194-6.\par \par Gasparini C, Tommasini A, Zauli G. The MDM2 inhibitor Nutlin-3 modulates dendritic cell-induced T cell proliferation. Hum Immunol 2012;73(4):342-5.\par \par Faletra F, Bruno I, Berti I, Pastore S, Pirrone A, Tommasini A. A red baby should not be taken too lightly. Acta Paediatr 2012;101(12):e573-7.\par \par Tommasini A, Not T, Ventura A. Ages of celiac disease: from changing environment to improved diagnostics. World J Gastroenterol 2011;17(32):3665-71.\par \par Piscianz E, Cuzzoni E, De Iudicibus S, Valencic E, Decorti G, Tommasini A. Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. Int Immunopharmacol 2011;11(12):2242-5.\par \par Marcuzzi A, De Leo L, Decorti G, Crovella S, Tommasini A, Pontillo A. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. Pediatr Res 2011;70(1):78-82.\par \par Passerini L, Olek S, Di Nunzio S, Barzaghi F, Hambleton S, Abinun M, Tommasini A, Vignola S, Cipolli M, Amendola M, Naldini L, Guidi L, Cecconi M, Roncarolo MG, Bacchetta R. Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. J Allergy Clin Immunol 2011;128(6):1376-1379.e1.\par \par Passerini L, Di Nunzio S, Gregori S, Gambineri E, Cecconi M, Seidel MG, Cazzola G, Perroni L, Tommasini A, Vignola S, Guidi L, Roncarolo MG, Bacchetta R. Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. Eur J Immunol 2011;41(4):1120-31.\par \par Villanacci V, Not T, Nascimbeni R, Ferrara F, Tommasini A, Manenti S, Antonelli E, Bassotti G. Gastrointestinal Foxp3 expression in normal, inflammatory and neoplastic conditions. Pathology 2011;43(5):465-71.\par \par Marcuzzi A, Decorti G, Pontillo A, Ventura A, Tommasini A. Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. Inflamm Res 2010;59(5):335-8.\par \par Lepore L, Paloni G, Caorsi R, Alessio M, Rigante D, Ruperto N, Cattalini M, Tommasini A, Zulian F, Ventura A, Martini A, Gattorno M. Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra. J Pediatr 2010;157(2):310-315.e1.\par \par Marcuzzi A, Tommasini A, Crovella S, Pontillo A. Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. Int Immunopharmacol 2010;10(6):639-42.\par \par De Leo L, Marcuzzi A, Decorti G, Tommasini A, Crovella S, Pontillo A. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res 2010;61(6):506-10.\par \par Freudenberg F, Wintergerst U, Roesen-Wolff A, Albert MH, Prell C, Strahm B, Koletzko S, Ehl S, Roos D, Tommasini A, Ventura A, Belohradsky BH, Seger R, Roesler J, G\'fcng\'f6r T. Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. J Allergy Clin Immunol 2010;125(4):943-946.e1.\par \par Tommasini A, Pirrone A, Palla G, Taddio A, Martelossi S, Crovella S, Ventura A. The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease?. Scand J Gastroenterol 2010;45(10):1141-9.\par \par }